MEA BioSurgery Market

MEA BioSurgery Market Size (2024 to 2029)

The size of the BioSurgery Market in the Middle East & Africa has been estimated at USD 30.77 billion in 2024 and estimated to be growing at a CAGR of 8.14%, to reach USD 45.51 billion by 2029.

Biosurgery products are mainly used in the post-surgical care of patients or the field of orthopedics, or even in the process of hard tissue regeneration in ortho-biologics. Most biosurgery products work on the principle of facilitating homeostasis and tissue healing in surgery.

Biosurgery products are used in various surgeries to minimize intra and post-operative complications. A variety of synthetic and biologic products like anti-adhesive agents, hemostatic agents, surgical sealing agents, bone graft substitutes, and soft tissue management are utilized in surgeries to prevent excessive blood loss or providing adhesion or wound/tissue sealing, and for the repair of damaged or weakened tissues or bones of a body. These advanced products help by enhancing physicians' work efficiency by controlling surgery-related difficulties in expensive and complicated surgeries.

The major driver of the Middle East and Africa Bio Surgery market is the increase in the geriatric population and the changing lifestyles worldwide. The rise in the number of spinal and sports injuries is also driving forward the biosurgery market as consumers also become aware of the latest medical practices.

However, the increasing costs of surgeries, the rising preference of consumers for minimally invasive surgery techniques, along the ethical concerns in some parts of the region are restraining the growth of the market in the Middle-East and Africa.

This research report on the Middle East and Africa BioSurgery Market has been segmented and sub-segmented into the following categories.

By Type

• Sealants

• Hemostatic Agents
• Adhesion Barriers
• Soft Tissue Attachments
• Bone Graft Substitutes
• Staple line Reinforcement Agents

By Application

• Orthopedic
• General
• Neurological
• Cardiovascular
• Reconstructive
• Gynecological
• Urological
• Thoracic Surgeries

By Country

• KSA

• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan, rest of MEA

Key market participants leading the Middle East & Africa Biosurgery Market profiled in the report are Baxter International, C.R. Bard, Johnson & Johnson, Covidien PLC, Getinge Group, B. Braun Melsungen AG, Cryolife Inc., Stryker Corporation, Hemostasis LLC., and Sanofi Group.